1. Home
  2. APPF vs PRAX Comparison

APPF vs PRAX Comparison

Compare APPF & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AppFolio Inc.

APPF

AppFolio Inc.

N/A

Current Price

$176.94

Market Cap

8.1B

Sector

Technology

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$297.51

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APPF
PRAX
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
9.6B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
APPF
PRAX
Price
$176.94
$297.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
15
Target Price
$296.11
$572.13
AVG Volume (30 Days)
374.7K
325.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.88
N/A
Revenue
$950,822,000.00
N/A
Revenue This Year
$19.69
N/A
Revenue Next Year
$16.52
$6,395.88
P/E Ratio
$46.08
N/A
Revenue Growth
19.72
N/A
52 Week Low
$161.13
$26.70
52 Week High
$325.90
$354.87

Technical Indicators

Market Signals
Indicator
APPF
PRAX
Relative Strength Index (RSI) 41.02 38.07
Support Level $161.13 $290.36
Resistance Level $191.16 $322.32
Average True Range (ATR) 6.93 16.77
MACD 1.71 -5.38
Stochastic Oscillator 47.22 13.28

Price Performance

Historical Comparison
APPF
PRAX

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: